Selenium Nanoparticles as Neuroprotective Agents: Insights into Molecular Mechanisms for Parkinson’s Disease Treatment
Molecular Neurobiology · 2025
DOI: 10.1007/s12035-024-04253-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Suganiya Umapathy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology, Department of Medical Biotechnology and Integrative Physiology, Saveetha School of Engineering, Saveetha Institute of Med…. Hauptthemen laut MEDLINE: Parkinson Disease, Selenium, Neuroprotective Agents, Nanoparticles. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 258 Literaturangaben.
Abstract (Originalsprache)
Oxidative stress and the accumulation of misfolded proteins in the brain are the main causes of Parkinson's disease (PD). Several nanoparticles have been used as therapeutics for PD. Despite their therapeutic potential, these nanoparticles induce multiple stresses upon entry. Selenium (Se), an essential nutrient in the human body, helps in DNA formation, stress control, and cell protection from damage and infections. It can also regulate thyroid hormone metabolism, reduce brain damage, boost immunity, and promote reproductive health. Selenium nanoparticles (Se-NPs), a bioactive substance, have been employed as treatments in several disciplines, particularly as antioxidants. Se-NP, whether functionalized or not, can protect mitochondria by enhancing levels of reactive oxygen species (ROS) scavenging enzymes in the brain. They can also promote dopamine synthesis. By inhibiting the aggregation of tau, α-synuclein, and/or Aβ, they can reduce the cellular toxicities. The ability of the blood-brain barrier to absorb Se-NPs which maintain a healthy microenvironment is essential for brain homeostasis. This review focuses on stress-induced neurodegeneration and its critical control using Se-NP. Due to its ability to inhibit cellular stress and the pathophysiologies of PD, Se-NP is a promising neuroprotector with its anti-inflammatory, non-toxic, and antimicrobial properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biotechnology, Department of Medical Biotechnology and Integrative Physiology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Thandalam, Tamil Nadu, 602105, India.
- Institute of Biotechnology, Department of Medical Biotechnology and Integrative Physiology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Thandalam, Tamil Nadu, 602105, India. ies…
- Biomedical Research Unit and Laboratory Animal Centre (BRULAC), Department of Anatomy, Saveetha Dental College, Chennai, Tamil Nadu, 600077, India.
- Department of Mechanical Engineering, Yeshwantrao Chavan College of Engineering, Nagpur, India.
- Department of Cariology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India. ajayguru.sdc@saveetha.com.
- Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, 603203, India. jesuaroa…
Zitieren
APA
Umapathy, S., Pan, I., Issac, P. K., Kumar, M. S. K., Giri, J., Guru, A., & Arockiaraj, J. (2025). Selenium Nanoparticles as Neuroprotective Agents: Insights into Molecular Mechanisms for Parkinson’s Disease Treatment. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04253-x
Vancouver
Umapathy S, Pan I, Issac PK, Kumar MSK, Giri J, Guru A, et al. Selenium Nanoparticles as Neuroprotective Agents: Insights into Molecular Mechanisms for Parkinson’s Disease Treatment. Molecular Neurobiology. 2025. doi:10.1007/s12035-024-04253-x
BibTeX
@article{Umapathy2025,
author = {Umapathy, Suganiya and Pan, Ieshita and Issac, Praveen Kumar and Kumar, Meenakshi Sundaram Kishore and Giri, Jayant and Guru, Ajay and Arockiaraj, Jesu},
title = {Selenium Nanoparticles as Neuroprotective Agents: Insights into Molecular Mechanisms for Parkinson’s Disease Treatment},
journal = {Molecular Neurobiology},
year = {2025},
doi = {10.1007/s12035-024-04253-x}
}
EUVIMED